Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PSMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07707232
What this trial is testing

Large Language Model-Assisted cTNM Annotation From Chinese PSMA PET/CT Reports

Who this might be right for
Prostate Cancer
First Affiliated Hospital of Wenzhou Medical University 4,600
Early research (Phase 1)Not Yet RecruitingNCT07090369
What this trial is testing

Phase Ib Trial of 177Lu-PSMA-I&T Therapy in Combination With Olaparib and Pembrolizumab in Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Peter MacCallum Cancer Centre, Australia 20
Not applicableLooking for participantsNCT07580196
What this trial is testing

Bilateral Versus Unilateral Lymph Node Dissection in High-Risk Prostate Cancer (BALANCE)

Who this might be right for
Prostate Cancer
University of Turin, Italy 820
Early research (Phase 1)Study completedNCT02552394
What this trial is testing

J591 in Patients With Advanced Prostate Cancer and Unfavorable Circulating Tumor Cell Counts

Who this might be right for
Prostate Cancer
Weill Medical College of Cornell University 10
Early research (Phase 1)Study completedNCT06641219
What this trial is testing

Clinical Evaluation of [177Lu]Lu-BQ7876 for Targeting of Prostate-Specific Membrane Antigen

Who this might be right for
Prostate Cancers
Tomsk National Research Medical Center of the Russian Academy of Sciences 7
Testing effectiveness (Phase 2)Study completedNCT06907641
What this trial is testing

Comparative Performance of 64Copper [64Cu]-SAR-bis-PSMA vs 68Ga PSMA-11 PET CT for the Detection of Prostate Cancer Recurrence in the Setting of Biochemical Failure Following Radical Prostatectomy

Who this might be right for
Prostate Cancer (Post Prostatectomy)
St Vincent's Hospital, Sydney 50
Not applicableLooking for participantsNCT06982469
What this trial is testing

High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy

Who this might be right for
Prostate CancerProstatectomyLocal Recurrence of Malignant Tumor of Prostate+2 more
Clinica Universidad de Navarra, Universidad de Navarra 20
Testing effectiveness (Phase 2)Study completedNCT05613842
What this trial is testing

Copper-64 SAR Bombesin in PSMA Negative Prostate Cancer (BOP)

Who this might be right for
Prostate Cancer
St Vincent's Hospital, Sydney 30
Post-approval studies (Phase 4)Looking for participantsNCT07169825
What this trial is testing

Evaluation of Targeted Radionuclide Therapy of Lu-177 PSMA in Patients With Compromised Renal and/or Bone Marrow Function

Who this might be right for
Lu-177 PSMA
M.D. Anderson Cancer Center 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT04663997
What this trial is testing

177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate Cancer

Who this might be right for
Prostate Cancer
Canadian Cancer Trials Group 200
Not applicableLooking for participantsNCT07691697
What this trial is testing

PSMA PET-Staged Comprehensive Progression-Directed Radiotherapy for Limited Progression in Prostate Cancer

Who this might be right for
Oligoprogressive Prostate CancerMetastatic Prostate Cancer
Affidea Nu-med Center of Oncological DIagnostics and Therapy 1,000
Not applicableLooking for participantsNCT06200558
What this trial is testing

ARON-3 Study: International Multicentric Retrospective Study to Collect Global Experiences in the Treatment of Patients With Metastatic PCa

Who this might be right for
Prostate Cancer
Hospital of Macerata 534
Not applicableLooking for participantsNCT06450548
What this trial is testing

Dynamic 68Ga-PSMA and 18F-FDG PET/CT Analysis Prior to 177Lu-PSMA

Who this might be right for
Prostate Cancer Metastatic
Centre Henri Becquerel 60
Not applicableStudy completedNCT06830408
What this trial is testing

Performance of 177Lu-PSMA-I&T for RLT in mCRPC - Prospective Multicenter Swiss Registry Study

Who this might be right for
mCRPC
University Hospital, Basel, Switzerland 250
Not applicableUnknownNCT06054789
What this trial is testing

Clinical Study on 68Ga-PSMA-33 for PET/CT Imaging of Prostate Cancer

Who this might be right for
Prostate Cancer
Nanjing First Hospital, Nanjing Medical University 8
Post-approval studies (Phase 4)Looking for participantsNCT07569926
What this trial is testing

Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence

Who this might be right for
Prostate Cancer
Blue Earth Diagnostics 142
Testing effectiveness (Phase 2)Ended earlyNCT03463889
What this trial is testing

Gallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid Cancer

Who this might be right for
Thyroid Gland Carcinoma
University of California, San Francisco 12
Very early researchStudy completedNCT04310540
What this trial is testing

PSMA PET/MRI or PSMA PET/CT for Evaluation of Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
Mayo Clinic 42
Not applicableLooking for participantsNCT07553754
What this trial is testing

Plasma Exosomal RNA Signature for Prostate Cancer Bone Metastasis

Who this might be right for
Prostate Cancer (Diagnosis)Bone MetastasisPSMA PET+4 more
Xijing Hospital 1,000
Not applicableNot Yet RecruitingNCT07656337
What this trial is testing

Effects of Direct Artery Injection on Prostate Cancer Drug Delivery and Tumor Uptake: Imaging-Based Prediction of Treatment Effectiveness

Who this might be right for
Prostate CancerProstate Adenocarcinoma
Lithuanian University of Health Sciences 10
Next Page